Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...

Ozempic and Wegovy also belong to the GLP-1 category. It is understood that Ms McGowan, who had worked as a nurse at University Hospital Monklands in Airdrie for more than 30 years, had purchased a ...

A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

The latest buzz around the popular weight loss drugs Ozempic, Mounjaro and Wegovy is to reduce the doseage and therefore avoid the vomiting and headaches that can happen on normal doses.

Novo Nordisk, the drug company that makes Ozempic and Wegovy, and Eli Lilly, the manufacturer of Mounjaro and Zepbound, do not deny that their drugs cause side effects, most often involving GI ...

Ozempic, Wegovy, Mounjaro, and similar drugs have exploded in popularity over the last few years. The medications are used to treat obesity and type 2 diabetes—and, as researchers are ...

As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The NHS rollout of appetite suppressing injections has been thrown into doubt after what is believed to be the first confirmed death linked to the controversial drugs ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the weight-loss effects of the two blockbuster slimming jabs ...